Atlas Trials

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

Clinical trial NCT03694392 · COMPLETED

Trial details

NCT number
NCT03694392
Sponsor
Kaiser Permanente
Status
COMPLETED
Study type
OBSERVATIONAL
InfluenzaPneumoniaLower Respiratory Tract InfectionAcute Myocardial InfarctionCongestive Heart FailureStroke
Start date
2018-09-16
Primary completion
2021-04-09
Enrollment
2776278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.